ArticleCancer2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Justin Loke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it